Obalon Therapeutics, Inc.
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Kelly Huang
- Full Time Employees
- 2
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 5421 Avenida Encinas Ste F Carlsbad CA United States of America 92008-4410
- IPO Date
- Oct 6, 2016
- CIK
- 0001427570
- Website
- obalon.com
- Similar Companies
- Business
- Obalon Therapeutics, Inc. (OBLN) operates as a medical device company focused on developing and commercializing innovative devices to treat obesity and overweight patients through weight loss facilitation; its primary offering is the Obalon Balloon System, an FDA-approved, swallowable gas-filled intragastric balloon designed for temporary placement in the stomach to induce satiety, comprising swallowable balloons, the Obalon Navigation System for placement tracking, the Touch Inflation Dispenser for semi-automated inflation with a gas mixture, and related disposable components. The company targets adults with BMI between 30 and 40 kg/m2 who commit to diet and exercise programs, deriving all revenue from the United States market. Founded in 2008 and headquartered in Carlsbad, California, Obalon Therapeutics emphasizes vertically integrated manufacturing and distribution of its balloon technology. In a major strategic development, Obalon Therapeutics merged with ReShape Lifesciences Inc. in a reverse merger transaction completed in June 2021, under which Obalon was acquired in an all-stock deal, resulting in the combined entity operating as ReShape Lifesciences with expanded minimally invasive weight loss solutions including the Obalon system alongside ReShape's Lap-Band and telehealth programs; the Obalon Balloon System is currently integrated into ReShape's portfolio but not commercially available as of late 2025 pending further commercial support plans. This merger followed Obalon's 2020 exploration of strategic alternatives amid COVID-19 impacts on elective procedures and prior operational shifts such as workforce reductions and a pivot to specialized treatment centers in 2019.
4 Penny Stocks Reddit Traders Are Buying Right Now
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger
Penny Stocks Are Heating Up, Here's 3 You Need to Know About
OBLN Stock Price: Over 20% Increase Explanation
Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
OBLN Stock Price: 30.04% Increase Explanation
Top Penny Stocks to Buy Today? Here's 3 to Watch in 2021
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
Which Penny Stocks Are The Most Resilient During a Bear Market?
OBLN Stock: Over 7% Increase Intraday Explanation
Best Biotech Penny Stocks to Buy Under $5? 4 To Check Out in May
Obalon Announces First Quarter 2021 Financial Results
Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc
Investing in Penny Stocks? Don't Before You Do These 3 Things
4 Biotech Penny Stocks That You Need to Know About
Market Update: The 10 Most Volatile Stocks Today
Top Reddit Penny Stocks To Buy Today? 3 To Watch Right Now
Penny Stocks to Buy During the Cryptocurrency Boom? Here's 3 to Watch
Obalon Announces Fourth Quarter and Full Year 2020 Financial Results
OBL Stock Price Increases Over 20% Pre-Market: Why It Happened